Lipohypertrophy in acromegaly induced by the new growth hormone receptor antagonist pegvisomant.
Maffei
Pietro
P
Martini
Chiara
C
Pagano
Claudio
C
Sicolo
Nicola
N
Corbetti
Francesco
F
D000005:Abdomen; D000172:Acromegaly / Q000188:drug therapy*; D000273:Adipose Tissue / Q000473:pathology*; D000328:Adult; D005260:Female; D019382:Human Growth Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D006984:Hypertrophy; D007279:Injections, Subcutaneous / Q000009:adverse effects; D008060:Lipodystrophy / Q000139:chemically induced*; D008297:Male
D019382:Human Growth Hormone; C406545:pegvisomant